image credit- shutterstock
The Saudi Society of Dermatology and Dermatologic Surgery (SSDDS), the leading professional body for dermatologists in Saudi Arabia, signed a Memorandum of Understanding (MoU) with AbbVie Saudi Arabia, the global biopharmaceutical research and development company, and Al Nahdi Medical Company, the largest retail pharmacy chain in the Middle East and Africa.
The MoU aims to collaborate on enhancing public health services, awareness programs, and advancing disease management through innovative healthcare solutions. The MoU also aims to strengthen the role of the Saudi Society of Dermatology through partnerships between the private and public entities to drive innovative healthcare solutions in line with Saudi Vision 2030.
SSDDS has also signed a Memorandum of Understanding (MoU) with Sanofi, a global leader in innovative healthcare. This strategic partnership aims to enhance dermatological care in the Kingdom. The agreement will focus on improving care for chronic and immunological skin diseases, particularly Type 2 inflammatory conditions like atopic dermatitis, which affects up to 20% of children in Saudi Arabia.
According to the Ministry of Health, dermatological conditions are among the top reasons for specialist clinic visits, with around 12% of primary healthcare center patients experiencing skin-related issues. Common conditions include atopic dermatitis, psoriasis, acne, and infectious diseases.
